InvestSMART

Xenitra Limited (ASX:XEN)

ALERT: Price-sensitive ASX Announcement for XEN
Current share price for XEN : $0.002 -0.001 (-33.33%)+
Announcement
Release
24 Aug 2026 9:57AM
Price at Release
$0.003
Full Release
download
Summary
Xenitra Limited has successfully raised A$1.5 million through a strategic placement of 500,000,000 new fully paid ordinary shares at A$0.003 per share, offering one free-attaching option for every two shares. This capital raise aims to accelerate high-margin sales growth by expanding inventory procurement and supplier capacity, fulfilling customer and distributor demands, and activating new brands across China. The funds will support Xenitra's transition from a low-margin distribution model to a diversified, higher-margin cross-border healthcare and digital commerce platform. Notable initiatives include the expansion of OTC Medicines, FSMP, and OPAL businesses, with significant achievements such as the partnership with Kangsheng Pharmaceuticals and the Joy Charm framework agreement, contributing to a stronger operating platform with improved sales and cash flow metrics.
Key Points
  • Xenitra Limited raises A$1.5 million through the placement of new shares.
  • Investors will receive free-attaching options with the new shares.
  • Funds will accelerate high-margin sales growth and expand inventory procurement.
  • Xenitra focuses on OTC Medicines, FSMP, and OPAL businesses.
  • The placement is managed by Novus Capital Limited.
  • Xenitra's OTC commercial activities include partnership with Kangsheng Pharmaceuticals.
  • FSMP growth targeted through the Joy Charm framework agreement.
  • OPAL generated over A$1.5 million in tokenised product sales.
  • Positive operating cash flow and gross-margin improvements reported.
  • Xenitra is transitioning to a higher-margin sales model.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.